Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Y-mAbs Therapeutics, Inc. - Common Stock (NQ:YMAB)

8.560 +0.010 (+0.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 549,586
Open 8.560
Bid (Size) 8.550 (29)
Ask (Size) 8.600 (10)
Prev. Close 8.550
Today's Range 8.550 - 8.570
52wk Range 3.550 - 16.11
Shares Outstanding 44,789,076
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNT, DAY, WOW, YMAB on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verint Systems Inc. (Nasdaq – VRNT), Dayforce, Inc. (NYSE – DAY), WideOpenWest, Inc. (NYSE – WOW), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)
From Brodsky & Smith LLC
Via GlobeNewswire

Performance

YTD
+7.4%
+7.4%
1 Month
+104.3%
+104.3%
3 Month
+75.8%
+75.8%
6 Month
+72.6%
+72.6%
1 Year
-38.3%
-38.3%

More News

Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DAY, WOW, YMAB, STAA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
A Look Ahead: Y-mAbs Therapeutics's Earnings Forecast
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Dayforce, Inc. (NYSE- DAY), WideOpenWest, Inc. (NYSE - WOW), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, TASK, YMAB on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Y-MABS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Y-mAbs Therapeutics, Inc. - YMAB
From Kahn Swick & Foti, LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WideOpenWest, Inc. (NYSE - WOW), BankFinancial Corporation (Nasdaq - BFIN), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)
From Brodsky & Smith LLC
Via GlobeNewswire
Deal Dispatch: Performance Food Group And Claire's Lead A Week Of Big Auctions, Retail Woes
Via Benzinga
Topics Bankruptcy
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
Shareholder Alert: The Ademi Firm Investigates Whether Y-mAbs Therapeutics Inc. is Obtaining a Fair Price for its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
Y-mAbs (YMAB) Q2 Revenue Falls 14%
Via The Motley Fool
Topics Intellectual Property
Earnings Scheduled For August 8, 2025
Via Benzinga
Y-MABS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Y-mAbs Therapeutics, Inc. - YMAB
From Kahn Swick & Foti, LLC
Via Business Wire
Unusual volume stocks are being observed in Wednesday's session.
Via Chartmill
Here are the top movers in Tuesday's session.
Via Chartmill
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA, YMAB, BASE, CORZ on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Nasdaq Down 50 Points; ISM Services PMI Declines In July
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB), Couchbase, Inc. (Nasdaq – BASE), Core Scientific, Inc. (Nasdaq - CORZ)
From Brodsky & Smith LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Tuesday's session: top gainers and losers
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session.
Via Chartmill
Dow Surges Over 100 Points; Pfizer Earnings Top Views
Via Benzinga
Topics Stocks
YMAB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Y-mAbs Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga

Frequently Asked Questions

Is Y-mAbs Therapeutics, Inc. - Common Stock publicly traded?
Yes, Y-mAbs Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Y-mAbs Therapeutics, Inc. - Common Stock trade on?
Y-mAbs Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Y-mAbs Therapeutics, Inc. - Common Stock?
The ticker symbol for Y-mAbs Therapeutics, Inc. - Common Stock is YMAB on the Nasdaq Stock Market
What is the current price of Y-mAbs Therapeutics, Inc. - Common Stock?
The current price of Y-mAbs Therapeutics, Inc. - Common Stock is 8.560
When was Y-mAbs Therapeutics, Inc. - Common Stock last traded?
The last trade of Y-mAbs Therapeutics, Inc. - Common Stock was at 09/02/25 04:00 PM ET
What is the market capitalization of Y-mAbs Therapeutics, Inc. - Common Stock?
The market capitalization of Y-mAbs Therapeutics, Inc. - Common Stock is 383.39M
How many shares of Y-mAbs Therapeutics, Inc. - Common Stock are outstanding?
Y-mAbs Therapeutics, Inc. - Common Stock has 383M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.